Chemed Corporation
CHE
$534.91
$0.030.01%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.80% | 1.63% | -0.10% | 3.09% | 3.85% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.80% | 1.63% | -0.10% | 3.09% | 3.85% |
| Cost of Revenue | 4.07% | 2.61% | 2.04% | 8.03% | 11.38% |
| Gross Profit | 19.91% | -0.30% | -3.82% | -6.23% | -10.40% |
| SG&A Expenses | 14.83% | 8.27% | -1.39% | 3.72% | -1.89% |
| Depreciation & Amortization | 4.46% | 5.34% | 3.15% | 3.42% | 3.48% |
| Other Operating Expenses | 200.00% | -115.69% | 21.88% | -6.92% | -29.73% |
| Total Operating Expenses | 6.05% | 3.76% | 1.41% | 7.03% | 8.46% |
| Operating Income | 31.02% | -10.74% | -7.05% | -18.89% | -22.74% |
| Income Before Tax | 28.42% | -7.14% | -12.22% | -17.31% | -24.21% |
| Income Tax Expenses | 26.87% | -5.77% | -3.72% | -23.55% | -18.83% |
| Earnings from Continuing Operations | 28.98% | -7.60% | -15.02% | -15.23% | -25.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.98% | -7.60% | -15.02% | -15.23% | -25.95% |
| EBIT | 31.02% | -10.74% | -7.05% | -18.89% | -22.74% |
| EBITDA | 25.90% | -8.42% | -6.01% | -15.64% | -18.77% |
| EPS Basic | 42.85% | -1.20% | -9.81% | -11.51% | -23.38% |
| Normalized Basic EPS | 42.24% | -0.71% | -2.24% | -13.68% | -21.58% |
| EPS Diluted | 43.70% | -0.41% | -9.09% | -10.80% | -23.23% |
| Normalized Diluted EPS | 43.06% | 0.14% | -1.44% | -12.95% | -21.38% |
| Average Basic Shares Outstanding | -9.71% | -6.48% | -5.78% | -4.20% | -3.35% |
| Average Diluted Shares Outstanding | -10.23% | -7.27% | -6.55% | -5.00% | -3.59% |
| Dividend Per Share | 20.00% | 20.00% | 20.00% | 20.00% | 25.00% |
| Payout Ratio | -0.15% | 0.21% | 0.33% | 0.36% | 0.61% |